Prolato Clinical Research Center (PCRC)

Houston, Texas 77054-2854

1 studies enrolling now · 5 studies all time

What they study most

ADPKD, Autosomal Dominant Polycystic Kidney, Focal Segmental Glomerulosclerosis (FSGS), Lupus Erythematosus, Lupus Nephritis, Systemic Lupus Erythematosus

Studies at this site

• A Study of Obexelimab in Patients With Systemic Lupus Erythematosus — Recruiting now
• Study of EQ001 (Itolizumab) in Systemic Lupus Erythematosus With or Without Active Proliferative Nephritis — Completed
• A Study of Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis (PALIZADE) — Stopped early
• A Study to Evaluate PF-06730512 in Adults With Focal Segmental Glomerulosclerosis (FSGS) — Stopped early
• Efficacy and Safety of Lixivaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease — Stopped early